Weiner, Ph.D. Weiner has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and bioequivalence assessment. Weiner is the co-author of Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications’ 4th ed. He is a codeveloper of PCNonlin, NONLIN84, and WinNonlin and has presented numerous workshops on the statistical evaluation of pharmacokinetic and bioavailability data. Weiner is currently an industry consultant and has held previous management positions including Chief Scientific Officer and Senior Vice President at Certara/Pharsight Corporation; Head of Biostatistics, Merrell Dow Pharmaceuticals; Vice President, Statistical Consultants, Inc.; Vice President, Syntex Development Research; Senior Vice President and Principal Scientist, Quintiles; and Senior Vice President and Global Head of Clinical Development at IVAX Research.
Jan 10, 2012 - need to change software [Software]. Since a renewal fee of Phoenix WinNonlin increases tremendously every year, i would like to change program to analyze pharmacokinetic and statistic. What other similar, reliable and common programmes do you recommend? Thank you, Pin. Super Police Telugu Movie Songs Free Download more. Albert King Tab Pdf To Jpg. Oct 3, 2017 - Phoenix is the most advanced, intuitive, and widely-used software for pharmacokinetic (PK), pharmacodynamic (PD) and toxicokinetic (TK) modeling and simulation. Included in this Phoenix rollout are Phoenix WinNonlin 8.0, Phoenix NLME 8.0, Phoenix Validation Suite 8.0 and Phoenix in vitro-in vivo. Feb 2, 2012 - Devising robust procedures using SAS transport files and CDISC nomenclature enables a readily switch between Phoenix WinNonlin and SAS (not to mention other software packages such as NONMEM) to produce TLFs in a format which is suitable for each individual study's reporting requirements.